Monthly Archives: February 2013

Governor Quinn Invites Biotech Professionals to Chicago

Gov Quinn

Governor Pat Quinn has long been a champion of the bioscience industry – both for its promise to help solve the world’s most pressing problems and as a means of elevating the economic development prospects for his state. The Governor has consistently championed educational reform, entrepreneurship, intellectual property protection, and industry regulation based on rigorous science. That is why he was named BIO’s Governor of the Year in 2011. We are furthermore honored that he Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Celebrating George Washington Carver’s Contributions to Industrial Biotech

Carver Award

Every February we celebrate Black History Month recognizing the contributions and accomplishments of African Americans and their role in U.S. history. George Washington Carver should be honored as an important figure influencing modern industrial biotechnology. The American scientist changed the nature of farming by using science to make everyday products from agricultural materials. As the leading figure of the “chemurgy” movement, the branch of applied chemistry that derives industrial products from agricultural raw materials, he Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Simpson Bowles Keynote to Address Debt, Taxes, Government Services and Politics

Jim Greenwood

I was recently asked what the single biggest threat to the biotechnology industry is today.  My answer was immediate – the biggest threat to biotech innovation is the unsustainable mismatch of spending and revenue in the U.S. federal budget. The enormous national debt and the huge annual budget deficits that feed it endanger America’s entire economic future – but the nation’s dire fiscal situation is particularly threatening to our industry. Part of the reason for Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , , ,

Biobuck M&A in Full Gear

Graph

The 2012 M&A results are in and trends are mixed. Last year was a down year in terms of total acquisitions and total dollar value amounts vs 2011.  What was not down however was the earnout structures embedded in these deals. More and more M&A transactions are looking like partnering deals structured with CVRs accounting for the bolus of the reported purchase price. Here is a look at therapeutic-focused acquisitions (valued at >$10M) over the Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

BIO IP Counsels Committee Conference: Spring 2013 Line-Up

San Diego

San Diego, California is the next site for the BIO IP Counsels Committee Conference.  On March 25, 2013, biotech IP counsel will gather for an event dedicated to providing in-house IP counsel opportunities to learn cutting edge issues, network with their peers, and to enjoy another great location.  Here is the session line-up and confirmed speakers with more speaker confirmations to come.  Visit BIO’s IP Counsels Committee Conference page to register and learn more. Pre-Conference Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , ,